Table 6.
Drug‐related adverse events
| BTFC | DTFC | |||
|---|---|---|---|---|
| N = 98 | N = 103 | |||
| N | % | N | % | |
| Patients with drug‐related adverse events | 26 | 26.5 | 21 | 20.4 |
| Eye disorders | ||||
| Blurred vision | 20 | 20.4 | 9 | 8.7 |
| Eye irritation | 2 | 2.0 | 10 | 9.7 |
| Corneal disorder | 1 | 1.0 | 0 | 0.0 |
| Eye pruritus | 1 | 1.0 | 0 | 0.0 |
| Conjunctival hyperaemia | 1 | 1.0 | 1 | 1.0 |
| Punctate keratitis | 1 | 1.0 | 1 | 1.0 |
| Iritis | 1 | 1.0 | 0 | 0.0 |
| Keratitis | 0 | 0.0 | 1 | 1.0 |
| Administration site irritation | 0 | 0.0 | 1 | 1.0 |
| Administration site pain | 0 | 0.0 | 2 | 1.9 |
| Systemic disorders | ||||
| Bradycardia | 1 | 1.0 | 0 | 0.0 |
| Arrhythmia | 1 | 1.0 | 0 | 0.0 |
| Dysgeusia | 1 | 1.0 | 1 | 1.0 |
BTFC = brinzolamide/timolol fixed combination; DTFC = dorzolamide/timolol fixed combination.